Osborne Clarke advised Sylphar NV and Karo Pharma AB on the purchase of the Satin Naturel business from Del Decus Enterprises Ltd.
With a high-quality aloe vera-based product portfolio, the Satin Naturel products are positioned in the “affordable luxury” price segment and appeal to a loyal customer base that values health and physical well-being. In addition to the Satin Naturel brands, trademarks and Amazon accounts, Karo Pharma AB has also assumed some employees as well as the management team of Del Decus Enterprises Ltd., to ensure the successful development and expanse of Satin Naturel products.
Karo Pharma AB is a Swedish healthcare company backed by EQT Partners, which recently acquired Sylphar International NV. Karo Pharma AB delivers smart choices for everyday healthcare. They own and commercialise branded, original over-the-counter products and prescription medicines. Their products are available in more than 60 countries. Karo Pharma AB is headquartered in Stockholm, Sweden and listed on Nasdaq Stockholm.
Sylphar NV is a Belgium based fast-growing and digital-first platform with a proven ability to grow and internationalise brands in the consumer health and beauty markets. Sylphar offers a portfolio of leading brands in these markets mainly sold through online marketplaces, web shops and e-pharmacies.
Del Decus Enterprises Ltd. is a natural cosmetics supplier founded by Deniz Genc that has quickly established itself as a leading seller on the European Amazon marketplaces with its brand Satin Naturel.
The team, that advised Sylphar NV and Karo Pharma, was led by Robin Eyben (partner responsibility) and Alexandra Nautsch (both Corporate / M&A) and consisted of Robert Marx (Corporate / M&A), Sarah Grigo (Commercial), Dr Hendrik Schöttle, Julia Kaufmann, Dr Florian Eisenmenger, Benjamin Schaum, Raphael Wager (all IT / Data Protection), Dr Tim Reinhard, Robert Briske, Dr Marius Tillwich (all IP), Dr Robert Rentsch, Johanna Reiland, Nora Hendricks-Wirtz (all Employment) and Jens Wrede (Tax).